Literature DB >> 24980568

Consider family history. In reply.

Günther Schellong, Jürgen Brämswig.   

Abstract

Mesh：

Year:  2014        PMID： 24980568      PMCID： PMC4078231          DOI： 10.3238/arztebl.2014.0404

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  4 in total

1.  Breast cancer in young women after treatment for Hodgkin's disease during childhood or adolescence--an observational study with up to 33-year follow-up.

Authors:  Günther Schellong; Marianne Riepenhausen; Karoline Ehlert; Jürgen Brämswig; Wolfgang Dörffel; Rita K Schmutzler; Kerstin Rhiem; Ulrich Bick
Journal:  Dtsch Arztebl Int       Date:  2014-01-06       Impact factor: 5.594

2.  Ovarian function following pelvic irradiation in prepubertal and pubertal girls and young adult women.

Authors:  Andreas Schuck; Victoria Hamelmann; Jürgen H Brämswig; Stefan Könemann; Claudia Rübe; Stefan Hesselmann; Dorothea Riesenbeck; Ekkehard Horst; Tobias Bölling; Michael Paulussen; Heribert Jürgens; Normann Willich
Journal:  Strahlenther Onkol       Date:  2005-08       Impact factor: 3.621

3.  Quality of life in long-term survivors following treatment for Hodgkin's disease during childhood and adolescence in the German multicentre studies between 1978 and 2002.

Authors:  Gabriele Calaminus; Wolfgang Dörffel; Katja Baust; Carmen Teske; Marianne Riepenhausen; Jürgen Brämswig; Hans-Henning Flechtner; Susanne Singer; Andreas Hinz; Günther Schellong
Journal:  Support Care Cancer       Date:  2014-01-12       Impact factor: 3.603

4.  Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies.

Authors:  Günther Schellong; Marianne Riepenhausen; Christian Bruch; Stefan Kotthoff; Johannes Vogt; Tobias Bölling; Karin Dieckmann; Richard Pötter; Achim Heinecke; Jürgen Brämswig; Wolfgang Dörffel
Journal:  Pediatr Blood Cancer       Date:  2010-12-01       Impact factor: 3.167
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.